Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin.

Hermiston ML, Gordon JI.

Science. 1995 Nov 17;270(5239):1203-7.

PMID:
7502046
2.

Cadherins: an integral role in inflammatory bowel disease and mucosal restitution.

Zbar AP, Simopoulos C, Karayiannakis AJ.

J Gastroenterol. 2004;39(5):413-21. Review.

PMID:
15175938
3.

Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.

Sturm A, de Souza HS, Fiocchi C.

Curr Drug Targets. 2008 May;9(5):381-7. Review.

PMID:
18473766
4.

The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease.

Strober W, Lúdvíksson BR, Fuss IJ.

Ann Intern Med. 1998 May 15;128(10):848-56. Review.

PMID:
9599198
5.

Etiology and pathogenesis of inflammatory bowel disease.

Schmidt C, Stallmach A.

Minerva Gastroenterol Dietol. 2005 Jun;51(2):127-45. Review.

PMID:
15990703
6.

Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions.

Dionne S, Ruemmele FM, Seidman EG.

Nestle Nutr Workshop Ser Clin Perform Programme. 1999;2:41-57; discussion 58-61. Review. No abstract available.

PMID:
11490627
7.

The gastrointestinal tract stem cell niche.

Yen TH, Wright NA.

Stem Cell Rev. 2006;2(3):203-12. Review.

PMID:
17625256
8.

The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Strober W, Nakamura K, Kitani A.

J Clin Invest. 2001 Mar;107(6):667-70. Review. No abstract available.

9.

Control of cell adhesion and compartmentalization in the intestinal epithelium.

Solanas G, Batlle E.

Exp Cell Res. 2011 Nov 15;317(19):2695-701. doi: 10.1016/j.yexcr.2011.07.019. Epub 2011 Jul 29. Review.

PMID:
21820431
10.

Advanced precancerous lesions in the small bowel mucosa.

Genta RM, Feagins LA.

Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):225-33. doi: 10.1016/j.bpg.2013.03.013. Review.

PMID:
23809242
11.

Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention.

Luna J, Masamunt MC, Lawrance IC, Sans M.

Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G703-8. doi: 10.1152/ajpgi.00504.2010. Epub 2011 Jan 13. Review.

12.

Proteomics and chronic inflammatory bowel diseases.

Felley-Bosco E, André M.

Pathol Res Pract. 2004;200(2):129-33. Review.

PMID:
15237921
13.

The role of the epithelial barrier in inflammatory bowel disease.

Nieuwenhuis EE, Blumberg RS.

Adv Exp Med Biol. 2006;579:108-16. Review. No abstract available.

PMID:
16620014
14.

The epidemiology and pathogenesis of neoplasia in the small intestine.

Schottenfeld D, Beebe-Dimmer JL, Vigneau FD.

Ann Epidemiol. 2009 Jan;19(1):58-69. doi: 10.1016/j.annepidem.2008.10.004. Review.

15.

Cytokine--intestinal epithelial cell interactions: implications for immune mediated bowel disorders.

Ruemmele FM, Seidman EG.

Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1998 Jan-Feb;39(1):1-8. Review.

PMID:
9553284
16.

Multicolor lineage tracing methods and intestinal tumors.

Yanai H, Tanaka T, Ueno H.

J Gastroenterol. 2013 Apr;48(4):423-33. doi: 10.1007/s00535-012-0736-3. Epub 2013 Jan 11. Review.

17.

Experimental intestinal cancer research with special reference to human pathology.

Pozharisski KM, Likhachev AJ, Klimashevski VF, Shaposhnikov JD.

Adv Cancer Res. 1979;30:165-237. Review. No abstract available.

PMID:
388992
18.

Inflammatory bowel disease and cancer.

Cola B.

Int J Colorectal Dis. 1989;4(2):128-33. Review. No abstract available.

PMID:
2664058

Supplemental Content

Support Center